Planet 13 Holdings Inc. (CNSX: PLTH)
Health Care · Pharmaceuticals · US
CA$0.22
+4.76% today · -45.0% 1Y
Planet 13 Holdings Inc. (CNSX: PLTH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $53.58M and employs 724 people.
Over the last twelve months the share price has lost 45.0%, trading between 0.16 and 0.55.
Tweenvest scores Planet 13 Holdings Inc. across four factors: quality 47/100, value 54/100, growth 0/100. Its strongest factor is value.
PLTH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $53.58M
- Revenue (TTM)
- $92.44M
- P/E
- —
- EPS
- -0.19
- Dividend yield
- —
- Beta (5Y)
- 1.71
- 52-week high
- CA$0.55
- 52-week low
- CA$0.16
- Avg volume (3M)
- —
- Shares outstanding
- 335.32M
- Employees
- 724
- Next earnings
- —
About Planet 13 Holdings Inc.
Planet 13 Holdings Inc. operates as a vertically integrated cannabis company, overseeing the cultivation, manufacturing, distribution, and marketing of cannabis and infused products. Its primary focus is serving both the medical and recreational marijuana markets within Nevada, U.S. Beyond its core cannabis activities, the company manages licensed cannabis dispensaries, a retail store for general merchandise, and an event space. Planet 13 further expands its portfolio by owning and operating hospitality venues, including Trece Eatery + Spirits, a coffee shop, and a pizzeria. Additionally, it offers consulting, educational resources, and various convenience services. The company is responsible for producing a diverse range of cannabis items such as chocolates, gummies, sparkling beverages, vapes, concentrates, and raw flower, which are marketed under its proprietary brands: TRENDI, Leaf & Vine, Dreamland, HaHa, and Medizin. The corporate headquarters for Planet 13 Holdings Inc. are situated in Las Vegas, Nevada.
- ISIN
- US72707C1080
- Listed since
- Jun 21, 2018
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.18 | -0.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.